mefenamic acid has been researched along with pf 04971729 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Han, DG; Yoon, IS; Yun, H | 1 |
Callegari, E; Goosen, TC; Lin, J; Sahasrabudhe, V; Tse, S | 1 |
1 trial(s) available for mefenamic acid and pf 04971729
Article | Year |
---|---|
Physiologically-Based Pharmacokinetic Modeling of the Drug-Drug Interaction of the UGT Substrate Ertugliflozin Following Co-Administration with the UGT Inhibitor Mefenamic Acid.
Topics: Adult; Area Under Curve; Bridged Bicyclo Compounds, Heterocyclic; Cyclooxygenase Inhibitors; Drug Interactions; Female; Glucuronosyltransferase; Healthy Volunteers; Humans; Male; Mefenamic Acid; Middle Aged; Models, Biological; Sodium-Glucose Transporter 2 Inhibitors; UDP-Glucuronosyltransferase 1A9; Uridine | 2021 |
1 other study(ies) available for mefenamic acid and pf 04971729
Article | Year |
---|---|
A novel high-performance liquid chromatographic method combined with fluorescence detection for determination of ertugliflozin in rat plasma: Assessment of pharmacokinetic drug interaction potential of ertugliflozin with mefenamic acid and ketoconazole.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Chromatography, High Pressure Liquid; Drug Interactions; Ketoconazole; Limit of Detection; Linear Models; Male; Mefenamic Acid; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Spectrometry, Fluorescence | 2019 |